Influence of butyrate on lipid metabolism, survival, and differentiation of colon cancer cells
- PMID: 1796008
- DOI: 10.1080/01635589109514150
Influence of butyrate on lipid metabolism, survival, and differentiation of colon cancer cells
Abstract
The present work was designed to study the differentiating effect of butyrate on LS174T cells after modification of their lipids with long-chain fatty acid (LCFA) supplementation. The LCFAs 18:1(n-9), 18:2(n-6), 20:4(n-6), 20:5(n-3), and 22:6(n-3) bound to added to the media of confluent cells for eight days. The fatty acid-to-albumin ratio was 3:1. The concentration of fatty acids in the media was 100 microM. On the last day, half of the flasks were treated with 2 mM butyrate. The data indicate that supplementation with polyunsaturated LCFAs having 20-22 carbon atoms resulted in a significant reduction in cell density and viability, whereas all LCFA supplementation reduced differentiation as measured by alkaline phosphatase activity. Butyrate treatment increased the density, viability, and differentiation of the tumor cells. The effect of butyrate on differentiation was mainly with cells supplemented with 18:1, 20:5, and 22:6. In the absence of LCFA supplementation, butyrate reduced the concentration of 22:5(n-6) in the cellular lipids. Also, butyrate modified the LCFAs incorporated in cells supplemented with 18:2 and 20:5, with changes occurring in 20:5(n-3), 22:5(n-3), and 22:5(n-6). Thus the present study suggests an interaction between butyrate and LCFA on differentiation and LCFA metabolism of human colon cancer cells.
Similar articles
-
Differential effect of butyrate on lipids of human colon cancer cells.Nutr Cancer. 1993;20(3):283-91. doi: 10.1080/01635589309514296. Nutr Cancer. 1993. PMID: 8108277
-
Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.J Cell Physiol. 1994 Aug;160(2):213-26. doi: 10.1002/jcp.1041600202. J Cell Physiol. 1994. PMID: 7913708
-
Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.Cancer Res. 1994 Nov 15;54(22):5992-6000. Cancer Res. 1994. PMID: 7954433
-
Regulation of the metabolism of polyunsaturated Fatty acids and butyrate in colon cancer cells.Curr Pharm Biotechnol. 2013;14(3):274-88. doi: 10.2174/1389201011314030004. Curr Pharm Biotechnol. 2013. PMID: 22201596 Review.
-
Revisiting long-chain fatty acid metabolism in Escherichia coli: integration with stress responses.Curr Genet. 2021 Aug;67(4):573-582. doi: 10.1007/s00294-021-01178-z. Epub 2021 Mar 19. Curr Genet. 2021. PMID: 33740112 Review.
Cited by
-
Butyrate and the colonocyte. Implications for neoplasia.Dig Dis Sci. 1996 Apr;41(4):727-39. doi: 10.1007/BF02213129. Dig Dis Sci. 1996. PMID: 8674394 Review.
-
Implication of the intestinal microbiome in complications of cirrhosis.World J Hepatol. 2016 Sep 28;8(27):1128-1136. doi: 10.4254/wjh.v8.i27.1128. World J Hepatol. 2016. PMID: 27721918 Free PMC article. Review.
-
Lipogenesis from n-butyrate in colonocytes. Action of reducing agent and 5-aminosalicylic acid with relevance to ulcerative colitis.Mol Cell Biochem. 1992 Dec 16;118(2):113-8. doi: 10.1007/BF00299390. Mol Cell Biochem. 1992. PMID: 1293506
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources